Michael Sage

Tuesday, April 30, 2019

Diasome: Father-Son Developing Nanotech to Improve Insulin Effectiveness

Diasome Pharmaceuticals, run by a father-son team in Ohio, is developing a nanotech compound that would make insulin work better in the liver.

From https://www.healthline.com/diabetesmine/diasome-liver-insulin-therapy



from
https://healthnews010.wordpress.com/2019/04/30/diasome-father-son-developing-nanotech-to-improve-insulin-effectiveness/

from https://karlfletcher.blogspot.com/2019/04/diasome-father-son-developing-nanotech.html

from
https://karlfletcher1.tumblr.com/post/184549717203

from https://davidrawlins1.blogspot.com/2019/04/diasome-father-son-developing-nanotech.html

from
https://davidrawlins1.tumblr.com/post/184549808876

from http://bit.ly/2DF0q9M

from
https://jamesprice01.tumblr.com/post/184549883504
Posted by Michael Sage at 5:31 AM
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest

No comments:

Post a Comment

Newer Post Older Post Home
Subscribe to: Post Comments (Atom)

About Me

My photo
Michael Sage
All animals are composed of cells, surrounded by a characteristic extracellular matrix composed of collagen and elastic glycoproteins. During development, the animal extracellular matrix forms a relatively flexible framework upon which cells can move about and be reorganised, making the formation of complex structures possible.
View my complete profile

Michael Sage

  • Official Site
  • YouTube
  • WordPress
  • Gravatar
  • Tumblr
  • Diigo
  • Google Drive
  • Weebly
  • Vimeo
  • Alternion
  • Pearltrees
  • Nimbus
  • Giphy
  • OneNote
  • Evernote
  • Disqus
  • Getpocket
  • Instapaper
  • Bitly
  • Pinterest
  • About Me
  • Dropbox
  • IFTTT
Simple theme. Powered by Blogger.